Close Menu

If you're affiliated with a New York City-based university or research institute (or have a collaborator who is), heads up: Stephen Albainy-Jenei at Patent Baristas has a post about the opportunity to win $250,000 in funding through the BioAccelerate NYC Prize competition. Funded with up to $1.25 million, the program aims to boost commercialization of the biomedical research conducted in New York.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.